EUVIMEDEUVIMED entdecken
Crossref

The Multifaceted Role of MAPK/ERK Signaling Pathways in Cancer Drug Resistance: An Update

Mehran Molavand, Amir Valizadeh, Maryam Majidinia, Bahman Yousefi

Advanced Pharmaceutical Bulletin · 09.08.2026

DOI: 10.34172/apb.46570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 09.08.2026. Verfasst von Mehran Molavand und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is among the leading causes of global mortality. In addition to uncontrolled proliferation, cancer cells activate survival pathways that favor the expansion of malignant cell populations. A critical component of these survival mechanisms is drug resistance, which often prevents the achievement of optimal therapeutic outcomes. At a cellular level, drug resistance arises from the modulation of multiple cellular processes, including apoptosis, DNA repair system, cancer stem cells, drug-metabolizing enzymes, and transporters. Among oncogenic signaling pathways, the MAPK/ERK cascade is frequently hyperactivated in cancer cells and serves as an upstream regulator of key effectors that drive drug resistance mechanisms. Consequently, patient profiling and therapeutic strategies aimed at targeting specific components of this pathway may not only counteract drug insufficiency but also facilitate personalized treatment approaches. This review provides an updated overview of the role of MAPK/ERK signaling in mediating drug resistance in cancer cells and discusses current and emerging therapeutic strategies, including combination therapies, pathway inhibitors, and novel drug development.

Zitieren

APA

Molavand, M., Valizadeh, A., Majidinia, M., & Yousefi, B. (2026). The Multifaceted Role of MAPK/ERK Signaling Pathways in Cancer Drug Resistance: An Update. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.46570

Vancouver

Molavand M, Valizadeh A, Majidinia M, Yousefi B. The Multifaceted Role of MAPK/ERK Signaling Pathways in Cancer Drug Resistance: An Update. Advanced Pharmaceutical Bulletin. 2026. doi:10.34172/apb.46570

BibTeX
@article{Molavand2026,
  author = {Molavand, Mehran and Valizadeh, Amir and Majidinia, Maryam and Yousefi, Bahman},
  title = {The Multifaceted Role of MAPK/ERK Signaling Pathways in Cancer Drug Resistance: An Update},
  journal = {Advanced Pharmaceutical Bulletin},
  year = {2026},
  doi = {10.34172/apb.46570}
}
Kostenlos starten →